ID Clinic Arkadiusz Pisula

Myslowice 22 trials 9 recruiting

22 Registered trials

9 Currently recruiting

Organisation

ID Clinic Arkadiusz Pisula

Location

Myslowice, Poland

Identifier

ORG-100042594

Address

Ul. Janowska 19, 41-400, Poland

Departments

Gastroenterology
Hepatology
Hepatology Clinic
ID Clinic
Investigator
N/A
NA
Not applicable

Clinical trials at this site (22)

Search interface

A clinical study to investigate the safety and tolerability of efimosfermin alfa injection in participants with known or suspected F2- or F3… Pending

2025-523674-16-00 Metabolic Dysfunction-Associated Steatohepatitis (MASH) 5
A pivotal clinical study to investigate the safety and efficacy of efimosfermin alfa injection in participants with biopsyconfirmed F2- or F… Pending

2025-523675-39-00 Metabolic Dysfunction-Associated Steatohepatitis (MASH) 5
Essentiale® liquid once-daily Phase III study Recruiting

2025-521678-32-00 MASLD (Metabolic Dysfunction-Associated Steatotic Liver 5 2026-03-03
AFFIRM: A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Pri… Recruiting

2024-516525-31-01 Primary Biliary Cholangitis 5 2025-07-14
Ph 3a, linerixibat, Long term safety and tolerability study in pts with PBC Recruiting

2023-503465-33-00 Cholestasis 5 2020-07-03
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) Recruiting

2025-522674-36-00 Metabolic Dysfunction-Associated Steatotic Liver Diseas 5 2026-03-24
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-fibrosis) Recruiting

2023-509912-27-00 Metabolic Dysfunction-Associated Steatotic Liver Diseas 5 2024-11-07
Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH (ENLIGHTEN-Cirrhosis) Recruiting

2023-510395-31-00 Metabolic Dysfunction-Associated Steatohepatitis (MASH) 5 2024-10-30
Study to learn about the safety of fazirsiran and if it can help people with alpha-1 antitrypsin liver disease with mild liver scarring (fib… Recruiting

2023-504198-19-00 Alpha-1 Antitrypsin Deficiency-Associated Liver Disease 5 2024-04-18
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnorma… Recruiting

2022-501943-34-00 Alpha-1 Antitrypsin Deficiency-Associated Liver Disease 5 2023-06-27
A Phase 2B Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Namodenoson in the Treatment of Non-Alcoholic St… Recruiting

2023-510548-19-00 Non-Alcoholic Steatohepatitis (NASH) with F1-3 fibrosis 4 2023-03-02
An Open-label study of patients with primary sclerosing cholangitis (PSC) treated with norucholic acid tablets Ended

2024-514292-18-00 Primary Sclerosing Cholangitis (PSC) 5 2025-03-24
A study to evaluate the safety and tolerability of seladelpar in subjects with primary biliary cholangitis Ended

2024-511753-22-00 Primary Biliary Cholangitis 5 2021-05-26
Research study on whether semaglutide works in people with non-alcoholic steatohepatitis (NASH) Ended

2023-506962-30-00 Non-alcoholic steatohepatitis (NASH) 5 2021-03-29
Clinical study to evaluate the efficacy and safety of Pioglitazone co-administration in patients with type II diabetes with insufficient gly… Ended

2023-508924-36-00 Type 2 diabetes mellitus (T2DM) 5 2024-08-20
Effects of NNC0194-0499, cagrilintide, and semaglutide alone or in combinations on liver damage and alcohol use in people with alcohol-relat… Ended

2023-508170-28-00 alcohol-related liver disease 4 2024-08-07
Open-Label Study of Imdusiran (AB-729) in Combination with Intermittent Dosing of Durvalumab in Subjects with Chronic HBV Infection Ended

2023-509573-23-00 Chronic HBV Infection 4 2024-07-16
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) Ended

2022-502899-23-00 Hepatic Encephalopathy (OHE) 5 2024-04-23
Phase 3 Study of Bepirovirsen in Nucleos(t)ide Analogue-treated Participants with Chronic Hepatitis B (B-Well 2) Ended

2023-504238-23-00 Hepatitis B, Chronic 5 2023-01-17
An Open Label Study to Evaluate A3907 in Adults with Primary Sclerosing Cholangitis (PSC) Ended

2022-500790-14-00 Primary Sclerosing Cholangitis (PSC) 4 2023-01-02
Research study on whether a combination of 2 medicines (NNC0194-0499 and Semaglutide) works in people with non-alcoholic steatohepatitis (NA… Ended

2023-506961-74-00 Non-alcoholic steatohepatitis (NASH) 4 2021-08-31
A study on the safety, efficacy and immune response following sequential treatment with an anti-sense oligonucleotide against chronic Hepati… Ended

2024-512352-38-00 Hepatitis B, Chronic 4 2019-03-28